膜性肾病合并抗肾小球基底膜病研究进展
Research Progress for Membranous Nephropathy Complicated with Anti-Glomerular Membrane Disease
DOI: 10.12677/ACM.2022.127986, PDF,   
作者: 宋曦玉:空军军医大学基础医学院,陕西 西安;查 阳, 何丽洁*:空军军医大学西京医院肾内科,陕西 西安;何春艳:空军第九八六医院肿瘤血液科,陕西 西安
关键词: 膜性肾病抗肾小球基底膜病免疫性肾病Membranous Nephropathy Anti-Glomerular Basement Membrane Disease Autoimmune Nephropathy
摘要: 膜性肾病(membranous nephropathy, MN)的典型病理表现是上皮下存在免疫复合物,而在临床中观察到MN患者组织中有新月体的形成,这种情况是十分罕见的。引起新月体型MN的常见原因之一是MN合并了抗肾小球基底膜病(glomerular basement membrane, GBM)。近年来逐渐有MN合并抗GBM病的病例及相关研究报道。在这一类疾病中,MN和抗GBM病可同时出现或先后发生,因此该病例既有MN的临床表现,又有抗GBM病的临床表现,在这些病例的血清中均未发现原发性MN的特征性抗体,但均存在抗GBM抗体阳性。MN合并抗GBM病确切的机制尚不明确,患者的免疫学特点、人类白细胞抗原易感性以及基于动物实验等方面的研究能够为探寻该病的临床表现和发病机制提供一些线索。由于抗GBM抗体的致病性,使得合并抗GBM病的MN患者往往肾脏预后不良,但临床医师对这一类疾病的认识尚不足,本文通过回顾近年来MN合并抗GBM病的病例报道,相关领域的研究进展,对其发病机制、临床病理特征、治疗及预后进行综述。
Abstract: The typical pathology of membranous nephropathy (MN) is the presence of immune complexes un-der the epithelium, while the formation of crescent bodies in the tissues of patients with MN is ob-served clinically, which is very rare. One of the common causes of crescentic MN is the combination of MN with glomerular basement membrane disease (GBM). In recent years, cases of MN combined with anti-GBM disease and related studies have been gradually reported. The exact mechanism of MN combined with anti-GBM disease is not clear, and the immunological characteristics of the pa-tients, their human leukocyte antigen susceptibility, and the animal-based studies are not clear. The exact mechanism of MN combined with anti-GBM disease is not clear, and the immunological characteristics of patients, their susceptibility to human leukocyte antigens, and studies based on animal experiments can provide some clues to explore the clinical presentation and pathogenesis of the disease. Due to the pathogenicity of anti-GBM antibodies, MN patients with combined anti-GBM disease often have a poor renal prognosis, but clinicians are not yet aware of this group of diseases. In this paper, we review the pathogenesis, clinicopathological features, treatment and prognosis of MN combined with anti-GBM disease by reviewing the case reports of MN combined with anti-GBM disease in recent years, and the progress of research in related fields.
文章引用:宋曦玉, 查阳, 何春艳, 何丽洁. 膜性肾病合并抗肾小球基底膜病研究进展[J]. 临床医学进展, 2022, 12(7): 6837-6843. https://doi.org/10.12677/ACM.2022.127986

参考文献

[1] Alsharhan, L. and Beck, L.J. (2021) Membranous Nephropathy: Core Curriculum 2021. American Journal of Kidney Diseases, 77, 440-453. [Google Scholar] [CrossRef] [PubMed]
[2] Liu, W., Gao, C., Liu, Z., Dai, H., Feng, Z., Dong, Z., et al. (2020) Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity. Frontiers in Immunology, 11, Article No. 1846. [Google Scholar] [CrossRef] [PubMed]
[3] Keri, K.C., Blumenthal, S., Kulkarni, V., Beck, L. and Chongkrairatanakul, T. (2019) Primary Membranous Nephropathy: Comprehensive Review and Historical Perspective. Postgraduate Medical Journal, 95, 23-31. [Google Scholar] [CrossRef] [PubMed]
[4] McAdoo, S.P. and Pusey, C.D. (2017) Anti-Glomerular Basement Membrane Disease. Clinical Journal of the American Society of Nephrology, 12, 1162-1172. [Google Scholar] [CrossRef
[5] Pedchenko, V., Kitching, A.R. and Hudson, B.G. (2018) Goodpas-ture’s Autoimmune Disease—A Collagen IV Disorder. Matrix Biology, 71-72, 240-249. [Google Scholar] [CrossRef] [PubMed]
[6] Segelmark, M. and Hellmark, T. (2019) Anti-Glomerular Base-ment Membrane Disease: An Update on Subgroups, Pathogenesis and Therapies. Nephrology Dialysis Transplantation, 34, 1826-1832. [Google Scholar] [CrossRef] [PubMed]
[7] Rodriguez, E.F., Nasr, S.H., Larsen, C.P., Sethi, S., Fidler, M.E. and Cornell, L.D. (2014) Membranous Nephropathy with Crescents: A Series of 19 Cases. American Journal of Kidney Diseases, 64, 66-73. [Google Scholar] [CrossRef] [PubMed]
[8] Troxell, M.L., Saxena, A.B. and Kambham, N. (2006) Concurrent Anti-Glomerular Basement Membrane Disease and Membranous Glomerulonephritis: A Case Report and Literature Re-view. Clinical Nephrology, 66, 120-127. [Google Scholar] [CrossRef
[9] Speer, C., Gaida, M.M., Waldherr, R., Nusshag, C., Kälble, F. and Zeier, M. (2018) Membranous Nephropathy Followed by Anti-Glomerular Basement Disease: A Case Report and Review of Clinical Presentation and Treatment. SAGE Open Medical Case Reports, 6, Article ID: 2050313X18807621. [Google Scholar] [CrossRef
[10] Patel, D., Nivera, N. and Tunkel, A.R. (2010) Anti-Glomerular Basement Membrane Disease Superimposed on Membranous Nephropathy: A Case Report and Review of the Literature. Journal of Medical Case Reports, 4, Article No. 237. [Google Scholar] [CrossRef] [PubMed]
[11] 包红梅, 张建春, 陈晓明, 等. 膜性肾病合并肾功能轻度受损的抗肾小球基底膜病一例报道及文献复习[J]. 临床肾脏病杂志, 2017, 17(4): 221-225.
[12] Kant, S., Kronbichler, A., Sharma, P. and Geetha, D. (2021) Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review. American Journal of Kidney Diseases, 79, 582-600.
[13] Ronco, P. and Debiec, H. (2020) Molecular Pathogenesis of Membranous Nephropathy. Annual Review of Pathology: Mechanisms of Disease, 15, 287-313. [Google Scholar] [CrossRef] [PubMed]
[14] Kurki, P., Helve, T., von Bonsdorff, M., Törnroth, T., Pettersson, E., Riska, H., et al. (1984) Transformation of Membranous Glomerulonephritis into Crescentic Glomerulo-nephritis with Glomerular Basement Membrane Antibodies. Serial Determinations of Anti-GBM before the Transfor-mation. Nephron, 38, 134-137. [Google Scholar] [CrossRef] [PubMed]
[15] Qu, Z., Cui, Z., Liu, G. and Zhao, Mi.-H. (2013) The Distribution of IgG Subclass Deposition on Renal Tissues from Patients with Anti-Glomerular Basement Membrane Disease. BMC Immu-nology, 14, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
[16] Jia, X.Y., Hu, S.Y., Chen, J.L., Qu, Z., Liu, G., Cui, Z., et al. (2014) The Clinical and Immunological Features of Patients with Combined Anti-Glomerular Basement Membrane Dis-ease and Membranous Nephropathy. Kidney International, 85, 945-952. [Google Scholar] [CrossRef] [PubMed]
[17] Hoshino, J., Hara, S., Ubara, Y., Takaya, H., Suwabe, T., Sawa, N., et al. (2005) Distribution of IgG Subclasses in a Biopsy Specimen Showing Membranous Nephropathy with Anti-Glomerular baseMent Membrane Glomerulonephritis: An Uncharacteristically Good Outcome with Corticosteroid Therapy. Ameri-can Journal of Kidney Diseases, 45, e67-e72. [Google Scholar] [CrossRef] [PubMed]
[18] Pedchenko, V., Bondar, O., Fogo, A.B., Vanacore, R., Voziyan, P., Kitching, A.R., et al. (2010) Molecular Architecture of the Good-pasture Autoantigen in Anti-GBM Nephritis. New England Journal of Medicine, 363, 343-354. [Google Scholar] [CrossRef
[19] Zhao, J., Cui, Z., Yang, R., Jia, X.Y., Zhang, Y. and Zhao, M.H. (2009) Anti-Glomerular Basement Membrane Autoantibodies against Different Target Antigens Are Associated with Disease Severity. Kidney International, 76, 1108- 1115. [Google Scholar] [CrossRef] [PubMed]
[20] Rees, A.J., Pe-ters, D.K., Amos, N., Welsh, K.I. and Batchelor, J.R. (1984) The Influence of HLA-Linked Genes on the Severity of Anti-GBM Antibody-Mediated Nephritis. Kidney International, 26, 445-450. [Google Scholar] [CrossRef] [PubMed]
[21] Hiki, Y., Kobayashi, Y., Itoh, I. and Kashiwagi, N. (1984) Strong Asso-ciation of HLA-DR2 and MT1 with Idiopathic Membranous Nephropathy in Japan. Kidney International, 25, 953-967. [Google Scholar] [CrossRef] [PubMed]
[22] Huang, C.C. (1989) Strong Association of HLA-DR3 in Chinese Patients with Idiopathic Membranous Nephropathy. Tissue Antigens, 33, 425-426. [Google Scholar] [CrossRef] [PubMed]
[23] Elder, G., Perl, S., Yong, J.L., Fletcher, J. and Mackie, J. (1995) Progression from Goodpasture’s Disease to Membranous Glomerulonephritis. Pathology, 27, 233-236. [Google Scholar] [CrossRef] [PubMed]
[24] Kerjaschki, D. and Neale, T.J. (1996) Molecular Mechanisms of Glomerular Injury in Rat Experimental Membranous Nephropathy (Heymann nephritis). Journal of the American Society of Nephrology, 7, 2518-2526. [Google Scholar] [CrossRef
[25] 陈文腾. 抗基底膜肾小球肾炎合并膜性肾病病例报告并文献复习[J]. 齐齐哈尔医学院学报, 2018, 39(14): 1627-1631.
[26] Dwyer, D.S., Bradley, R.J., Urquhart, C.K. and Kearney, J.F. (1983) Naturally Occurring Anti-Idiotypic Antibodies in Myasthenia Gravis Patients. Nature, 301, 611-614. [Google Scholar] [CrossRef] [PubMed]
[27] Glassock, R.J. (2020) Membranous Nephropathy Due to Anti-GBM Anti-bodies of Mice and Men. American Journal of Nephrology, 51, 96-98. [Google Scholar] [CrossRef] [PubMed]
[28] McAdoo, S.P. and Pusey, C.D. (2018) Antiglomerular Basement Mem-brane Disease. Seminars in Respiratory and Critical Care Medicine, 39, 494-503. [Google Scholar] [CrossRef] [PubMed]
[29] Ogawara, A., Harada, M., Ichikawa, T., Fujii, K., Ehara, T. and Ko-bayashi, M. (2017) Coexistence of Anti-Glomerular Basement Membrane Glomerulonephritis and Membranous Nephropathy in a Female Patient with Preserved Renal Function. The Tohoku Journal of Experimental Medicine, 243, 335-341. [Google Scholar] [CrossRef] [PubMed]
[30] Nikolopoulou, A., Huang-Doran, I., McAdoo, S.P., Griffith, M.E., Cook, H.T. and Pusey, C.D. (2019) Membranous Glomerulonephritis with Crescents. Kidney International Re-ports, 4, 1577-1584. [Google Scholar] [CrossRef] [PubMed]
[31] Nasr, S.H., Collins, A.B., Alexander, M.P., Schraith, D.F., Herrera Hernandez, L., Fidler, M.E., et al. (2016) The Clinicopathologic Characteristics and Outcome of Atypical An-ti-Glomerular Basement Membrane Nephritis. Kidney International, 89, 897-908. [Google Scholar] [CrossRef] [PubMed]
[32] Rovin, B.H., Adler, S.G., Barratt, J., Bridoux, F., Burdge, K.A., Chan, T.M., et al. (2021) Executive Summary of the KDIGO 2021 Guideline for the Management of Glomerular Dis-eases. Kidney International, 100, 753-779. [Google Scholar] [CrossRef] [PubMed]
[33] Stummvoll, G., Aringer, M., Handisurya, A. and Derfler, K. (2017) Immunoadsorption in Autoimmune Diseases Affecting the Kidney. Seminars in Nephrology, 37, 478-487. [Google Scholar] [CrossRef] [PubMed]
[34] Shah, Y., Mohiuddin, A., Sluman, C., Daryanani, I., Led-son, T., Banerjee, A., et al. (2012) Rituximab in Anti-Glomerular Basement Membrane Disease. QJM, 105, 195-197. [Google Scholar] [CrossRef] [PubMed]
[35] Santos, J.E., Fiel, D., Santos, R., Vicente, R., Aguiar, R., Santos, I., et al. (2020) Rituximab Use in Adult Glomerulopathies and Its Rationale. Brazilian Journal of Nephrology, 42, 77-93. [Google Scholar] [CrossRef] [PubMed]
[36] Bandak, G., Jones, B.A., Li, J., Yee, J. and Umanath, K. (2014) Rituximab for the Treatment of Refractory Simultaneous Anti-Glomerular Basement Membrane (Anti-GBM) and Membranous Nephropathy. Clinical Kidney Journal, 7, 53-56. [Google Scholar] [CrossRef] [PubMed]